The Newsroom

Investigations  /  05.17.2019

Shareholder Investigation of Lannett Company

Shareholder Class Action Alleging Lannett Company (LCI) Made Materially False and Misleading Statements Survives Motion to Dismiss

Investors filed a class action complaint against Lannett Company (LCI) for alleged violations of the Securities Exchange Act of 1934. According to the complaint, since 2013, Lannett’s business strategy has been to collusively enter into industry-wide anti-competitive agreements with other generic drug manufacturers. Extensive regulatory investigations revealed that Lannett was involved in an industry-wide conspiracy to fix prices and allocate territories for the sale of at least 18 different generic medications. Nevertheless, Lannett insiders misled investors by stating that price increases were the result of legitimate and competitive market forces contrary to their knowledge that the market was being driven by antitrust violations.  The complaint further alleges that Lannett insiders misrepresented the scope of their investigations into potential antitrust violations and the likelihood that Lannett would be implicated in the broader price-fixing procecutions.  Capitalizing on Lannett’s artificially inflated stock prices, certain executives made nearly $10 million in insider sales.  As a result of its price-fixing, Lannett is now defending itself against regulatory inquiries and investigations and private lawsuits alleging securities fraud, consumer deception, and violations of state and federal antitrust laws.  On May 15, 2019, U.S. District Court Judge Wendy Beetlestone denied Lannett’s motion to dismiss plaintiffs’ complaint, paving the way for litigation to proceed.

Lannett Company (LCI) Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can please send us a message via the Shareholder Information form below.

Shareholder Information

  • Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

How can we help you?

CONTACT US TODAY | 1-800-350-6003 or info@robbinsarroyo.com

Tell us your concerns